These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1186 related articles for article (PubMed ID: 17643398)

  • 1. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
    Maeng S; Zarate CA; Du J; Schloesser RJ; McCammon J; Chen G; Manji HK
    Biol Psychiatry; 2008 Feb; 63(4):349-52. PubMed ID: 17643398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
    Koike H; Iijima M; Chaki S
    Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
    Koike H; Chaki S
    Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
    Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
    Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice.
    Nguyen L; Matsumoto RR
    Behav Brain Res; 2015 Dec; 295():26-34. PubMed ID: 25804358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition.
    Zanos P; Piantadosi SC; Wu HQ; Pribut HJ; Dell MJ; Can A; Snodgrass HR; Zarate CA; Schwarcz R; Gould TD
    J Pharmacol Exp Ther; 2015 Oct; 355(1):76-85. PubMed ID: 26265321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons.
    El Iskandrani KS; Oosterhof CA; El Mansari M; Blier P
    J Psychopharmacol; 2015 Jul; 29(7):792-801. PubMed ID: 25759403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of GluA1 expression by ketamine and memantine.
    Zhang K; Yamaki VN; Wei Z; Zheng Y; Cai X
    Behav Brain Res; 2017 Jan; 316():152-159. PubMed ID: 27599619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
    Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine: The final frontier or another depressing end?
    Sial OK; Parise EM; Parise LF; Gnecco T; Bolaños-Guzmán CA
    Behav Brain Res; 2020 Apr; 383():112508. PubMed ID: 32017978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
    Ren Z; Pribiag H; Jefferson SJ; Shorey M; Fuchs T; Stellwagen D; Luscher B
    Biol Psychiatry; 2016 Sep; 80(6):457-468. PubMed ID: 27062563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test.
    Wang X; Yang Y; Zhou X; Wu J; Li J; Jiang X; Qu Q; Ou C; Liu L; Zhou S
    Psychiatry Res; 2011 Jan; 185(1-2):248-53. PubMed ID: 20580983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
    Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
    Miller OH; Moran JT; Hall BJ
    Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory consolidation induces N-methyl-D-aspartic acid-receptor- and Ca2+/calmodulin-dependent protein kinase II-dependent modifications in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor properties.
    Bevilaqua LR; Medina JH; Izquierdo I; Cammarota M
    Neuroscience; 2005; 136(2):397-403. PubMed ID: 16182449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test.
    Ghasemi M; Raza M; Dehpour AR
    J Psychopharmacol; 2010 Apr; 24(4):585-94. PubMed ID: 19351802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule.
    Hillhouse TM; Porter JH
    Behav Pharmacol; 2014 Feb; 25(1):80-91. PubMed ID: 24370559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT
    Sayson LV; Botanas CJ; Custodio RJP; Abiero A; Kim M; Lee HJ; Kim HJ; Yoo SY; Lee KW; Ryu HW; Acharya S; Kim KM; Lee YS; Cheong JH
    Psychopharmacology (Berl); 2019 Jul; 236(7):2201-2210. PubMed ID: 30891619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests.
    Andreasen JT; Gynther M; Rygaard A; Bøgelund T; Nielsen SD; Clausen RP; Mogensen J; Pickering DS
    Neurosci Lett; 2013 Jun; 546():6-10. PubMed ID: 23643996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of NMDA-AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test.
    Dybała M; Siwek A; Poleszak E; Pilc A; Nowak G
    J Neural Transm (Vienna); 2008 Nov; 115(11):1519-20. PubMed ID: 18839056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.